Related Experiment Video
Updated: May 26, 2026
10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
PET studies in Parkinson's disease motor and cognitive dysfunction
1Centre for Neuroscience, Department of Medicine, Imperial College London, Hammersmith Hospital, London, UK. nicola.pavese@imperial.ac.uk
Parkinsonism & Related Disorders
|December 15, 2011
Summary
Positron emission tomography (PET) advances Parkinson's disease (PD) research by visualizing brain changes. PET scans reveal dopaminergic and non-dopaminergic pathways, aiding understanding of motor and non-motor symptoms.
Area of Science:
- Neuroscience
- Medical Imaging
- Neurology
Background:
- Positron emission tomography (PET) has significantly advanced Parkinson's disease (PD) research.
- PET aids in understanding neurobiology, pathophysiology, and treatment complications in PD.
Purpose of the Study:
- To review PET findings on the pathophysiology and treatment of motor and cognitive impairments in PD.
- To highlight PET's role in assessing dopaminergic and non-dopaminergic pathways in PD.
Main Methods:
- Utilizing PET imaging with various radiotracers, including [(18)F]-Fluorodopa.
- Analyzing metabolic changes and evaluating monoaminergic and cholinergic pathways.
- Assessing β-amyloid pathology in PD patients using specific imaging agents.
Main Results:
- PET measurements of dopaminergic function correlate with PD stage and motor symptoms like bradykinesia and rigidity.
- Metabolic brain network analysis links specific networks to motor features such as bradykinesia and tremor.
- Newer tracers allow evaluation of non-dopaminergic pathways involved in non-motor PD symptoms (depression, cognitive impairment).
Conclusions:
- PET is crucial for understanding PD neurobiology, motor and non-motor symptoms, and treatment effects.
- PET imaging provides insights into dopaminergic and non-dopaminergic dysfunction in Parkinson's disease.
- PET facilitates the assessment of co-existing pathologies like Alzheimer's in PD patients.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...